Search

Your search keyword '"Rogalska – Plonska, Magdalena"' showing total 12 results
Start Over Author "Rogalska – Plonska, Magdalena"
12 results on '"Rogalska – Plonska, Magdalena"'

1. Elevated levels of soluble glycoprotein V - The plasma marker of platelet activation by thrombin in patients with early stage primary biliary cholangitis (PBC)

Author

Rogalski, Pawel, Bogdanowska – Charkiewicz, Dagmara, Rogalska – Plonska, Magdalena, Lukaszewicz-Zajac, Marta, Kostecka – Roslen, Ines, Mroczko, Barbara, Dabrowska, Milena, Wasielica – Berger, Justyna, Aleksiejuk, Elzbieta, Antonowicz, Stefania, Dabrowski, Andrzej, Daniluk, Jaroslaw, and Janica, Jacek

Published
2023
Full Text
View/download PDF

5. Endoscopic management of leaks and fistulas after bariatric surgery: a systematic review and meta-analysis

Author

Rogalski, Pawel, primary, Swidnicka-Siergiejko, Agnieszka, additional, Wasielica-Berger, Justyna, additional, Zienkiewicz, Damian, additional, Wieckowska, Barbara, additional, Wroblewski, Eugeniusz, additional, Baniukiewicz, Andrzej, additional, Rogalska-Plonska, Magdalena, additional, Siergiejko, Grzegorz, additional, Dabrowski, Andrzej, additional, and Daniluk, Jaroslaw, additional

Published
2020
Full Text
View/download PDF

7. Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding

Author

Rogalski, Pawel, primary, Rogalska-Plonska, Magdalena, additional, Wroblewski, Eugeniusz, additional, Kostecka-Roslen, Ines, additional, Dabrowska, Milena, additional, Swidnicka-Siergiejko, Agnieszka, additional, Wasielica-Berger, Justyna, additional, Cydzik, Mariusz, additional, Hirnle, Tomasz, additional, Flisiak, Robert, additional, and Dabrowski, Andrzej, additional

Published
2019
Full Text
View/download PDF

8. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history*

Author

Rogalski, Pawel, primary, Rogalska-Plonska, Magdalena, additional, Wroblewski, Eugeniusz, additional, Kostecka-Roslen, Ines, additional, Dabrowska, Milena, additional, Swidnicka-Siergiejko, Agnieszka, additional, Wasielica-Berger, Justyna, additional, Cydzik, Mariusz, additional, Hirnle, Tomasz, additional, Dobrzycki, Slawomir, additional, Flisiak, Robert, additional, and Dabrowski, Andrzej, additional

Published
2019
Full Text
View/download PDF

12. Exacerbation of chronic hepatitis B during chemotherapy due to testicular seminoma.

Author

Parfieniuk-Kowerda A, Rogalska-Plonska M, Lapinski WT, and Flisiak R

Subjects
Adult, Humans, Male, Seminoma complications, Testicular Neoplasms complications, Virus Activation drug effects, Antineoplastic Agents adverse effects, Hepatitis B, Chronic complications, Seminoma drug therapy, Testicular Neoplasms drug therapy
Abstract

Chronic hepatitis B is often asymptomatic until it progresses to advanced stage. The natural course of disease includes flares and periods of decreased inflammatory activity. Immune decline status is proven risk factor for exacerbation of viral hepatitis. Anticancer chemotherapy in chronic HBsAg carriers is known to promote viral replication. Return of immunocompetence after withdrawal of immunosuppressant might result in liver damage. We describe case of a patient with chronic HBV infection who developed hepatitis flare subsequently to the cessation of anti-viral treatment and introduction of chemotherapy due to testicular seminoma. Patients with history of HBV infection who receive immunosuppressive treatment are at risk of HBV reactivation or exacerbation of hepatitis. During immunosuppressive treatment enhanced HBV replication and inhibition of CTL without evident liver injury is observed. Restoration of immune system after withdrawal of immunosuppressant allows recognizing increased expression of HBV antigens in hepatocytes. Intensive elimination of infected hepatocytes could occur resulting in liver tissue necrosis, active hepatitis and liver decompensation. It is recommended for HBV infected patients on immunosuppressive treatment to receive antiviral therapy, particularly with the lowest risk for the selection of mutations, regardless the stage of infection.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results